As-Needed Rescue Treatment with Albuterol–Budesonide for Mild Asthma, with Monica Kraft, MD

Published Date: 22 May 2025

Phase 3 BATURA data reveal a 47% reduction in the risk of severe exacerbations in mild asthma with albuterol/budesonide (Airsupra) versus albuterol alone.

Read Full News

Latest News

Air Trapping Predicts Pneumothorax After BLVR

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

Sanofi Says Rare Lung Disease Drug Outperforms Standard Care in Trial

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

News All Time

Doc Gave Patients Recalled CPAPs 'Fixed' by His Own Children

Sleep medicine specialist was sentenced to a year in prison and will pay $350K in restitution

Cooking and Dementia Risk; High-Dose vs Standard-Dose Flu Shot

Also in TTHealthWatch: replacing the aortic valve in asymptomatic people

Alzheimer's Risk May Be Influenced by Flu Shots

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia

Here's How Many Doctors and Nurses Are Getting Flu or COVID Shots

Nurses in particular do not seem to be fans of the COVID-19 vaccine

Trump: 'It Was Me as a Doctor'; Lululemon PFAS Probe; Dick Vitale's Fifth Cancer Dx

Health news and commentary gathered by MedPage Today staff

Quiz Time: How Are Flu Shots and Alzheimer's Linked?

You passed medical training, now see if you can pass our weekly quiz

Doc Detained by Border Patrol; Lady Gaga Sick, Cancels Show; Sexy Chocolate Recall

Health news and commentary gathered by MedPage Today staff

Amoxicillin Alone Holds Up for Acute Sinusitis

Observational study supports efficacy, safety compared with amoxicillin-clavulanate

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Zongertinib in phase I trial showed sustained efficacy in aggressive disease

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Findings of TB DNA will require larger studies to confirm clinical relevance, says researcher

Congresswoman Tied to COVID Fraud Resigns; DOD Ends Flu Vax Mandate; USPSTF Overhaul

Health news and commentary gathered by MedPage Today staff

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

In a post-pandemic landscape, the drug didn't top usual care at stopping hospitalization, death

Bronchial Casts: An Unusual Complication of Wildfire Smoke Inhalation

Case is a "graphic demonstration" of emergent, severe impacts of forest fires for everyday people

Portable Tuberculosis Diagnostic Tool Matched Traditional Tests' Results

The MiniDock MTB could expand access to molecular testing in peripheral health centers

Why Is a Healthy 22-Year-Old Male Suddenly Fainting and Short of Breath?

Careful questioning about patient's recent behaviors gave vital clue

Recommended News For You

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

AI tool automates liver tumor detection and monitoring

New clinical recommendation for local treatment of oligometastatic lung cancer.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

Recommended Articles For You

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

1.

A Closer Look at Breast Cancer: Examining the Ultrasound Images

2.

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection

3.

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction

4.

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown

5.

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

5.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot